For instance, IFN‐I, either produced locally by tumour cells or when administered systemically in mice, can induce a cDC2 activation state that is characterised by the expression of interferon‐stimulated genes (ISG+ cDC2), conferring their capacity to stimulate tumour‐reactive CTL responses in a dominant fashion [24]. Here, STING1 is linked to neoplasm.